BINDING PROFILE OF BENEXTRAMINE AT NEUROPEPTIDE-Y RECEPTOR SUBTYPES IN RAT-BRAIN AREAS

被引:10
作者
MELCHIORRE, C [1 ]
ROMUALDI, P [1 ]
BOLOGNESI, ML [1 ]
DONATINI, A [1 ]
FERRI, S [1 ]
机构
[1] UNIV BOLOGNA,DEPT PHARMACOL,I-40126 BOLOGNA,ITALY
关键词
NEUROPEPTIDE Y; BENEXTRAMINE; NONPEPTIDE ANTAGONIST; NEUROPEPTIDE Y RECEPTOR SUBTYPE; BINDING AFFINITY;
D O I
10.1016/0014-2999(94)90228-3
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Binding studies in rat whole brain, frontoparietal cortex and brainstem membrane preparations revealed that benextramine displaced [H-3]neuropeptide Y specific binding from a low and a high affinity site with IC50 values in the mu M (36 +/- 2, 4.4 +/- 1.4 and 300 +/- 120 mu M, respectively) and the pM (29.3 +/- 12.1, 0.35 +/- 0.11 and 0.42 +/- 0.03 pM, respectively) range, whereas in rat hippocampus benextramine displaced [H-3]neuropeptide Y specific binding from one site only with an IC50 value of 22.8 +/- 5.7 mu M. With the exception of frontoparietal cortex binding assay, benextramine was not able to completely inhibit [H-3]neuropeptide Y specific binding revealing the presence of a benextramine nonsensitive third binding site. Benextramine pretreatment followed by membrane washing demonstrated that benextramine inhibited irreversibly both high and low affinity sites.
引用
收藏
页码:93 / 98
页数:6
相关论文
共 15 条
[1]
BENEXTRAMINE - A LONG-LASTING NEUROPEPTIDE-Y RECEPTOR ANTAGONIST [J].
DOUGHTY, MB ;
CHU, SS ;
MILLER, DW ;
LI, K ;
TESSEL, RE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 185 (01) :113-114
[2]
BENEXTRAMINE-NEUROPEPTIDE-Y (NPY) BINDING-SITE INTERACTIONS - CHARACTERIZATION OF H-3 NPY BINDING-SITE HETEROGENEITY IN RAT-BRAIN [J].
DOUGHTY, MB ;
LI, K ;
HU, L ;
CHU, SS ;
TESSEL, R .
NEUROPEPTIDES, 1992, 23 (03) :169-180
[3]
DUMONT Y, 1993, J NEUROSCI, V13, P73
[4]
MOLECULAR-CLONING OF A NOVEL-G PROTEIN-COUPLED RECEPTOR THAT MAY BELONG TO THE NEUROPEPTIDE RECEPTOR FAMILY [J].
EVA, C ;
KEINANEN, K ;
MONYER, H ;
SEEBURG, P ;
SPRENGEL, R .
FEBS LETTERS, 1990, 271 (1-2) :81-84
[5]
GRUNDEMAR L, 1991, J PHARMACOL EXP THER, V258, P633
[6]
NEUROPEPTIDE-Y EFFECTOR SYSTEMS - PERSPECTIVES FOR DRUG DEVELOPMENT [J].
GRUNDEMAR, L ;
HAKANSON, R .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (05) :153-159
[7]
CLONED HUMAN NEUROPEPTIDE-Y RECEPTOR COUPLES TO 2 DIFFERENT 2ND MESSENGER SYSTEMS [J].
HERZOG, H ;
HORT, YJ ;
BALL, HJ ;
HAYES, G ;
SHINE, J ;
SELBIE, LA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (13) :5794-5798
[8]
LARHAMMAR D, 1992, J BIOL CHEM, V267, P10935
[9]
LI W, 1991, EUR J PHARM-MOLEC PH, V297, P89
[10]
TETRAMINE DISULFIDES - A NEW TOOL IN ALPHA-ADRENERGIC PHARMACOLOGY [J].
MELCHIORRE, C .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1981, 2 (08) :209-211